These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 4147030

  • 21. Synergism between lymph node and bone marrow cells for production of granulocytes. I. Requirement for immunocompetent cells.
    Kanamaru A, Kitamura Y, Kawata T, Okano K.
    Exp Hematol; 1974; 2(1):35-42. PubMed ID: 4155687
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Inhibition of normal allogeneic responder cells in mouse mixed leukocyte culture by long-passage AKR leukemic lymphoblasts.
    Rodey GE, Sprader JC, Bortin MM.
    Cancer Res; 1974 Jun; 34(6):1289-94. PubMed ID: 4275007
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prevention of marrow allograft rejection with radioactive strontium: evidence for marrow-dependent effector cells.
    Bennett M.
    J Immunol; 1973 Feb; 110(2):510-6. PubMed ID: 4405320
    [No Abstract] [Full Text] [Related]

  • 27. Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice.
    Truitt RL, Bortin MM, Rimm AA.
    Transplant Proc; 1980 Mar; 12(1):143-6. PubMed ID: 6966095
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Graft versus leukemia for "cell cure" of long-passage AKR leukemia after chemoradiotherapy.
    Saltzstein EC, Glasspiegel JS, Rimm AA, Giller RH, Bortin MM.
    Cancer Res; 1972 Aug; 32(8):1658-62. PubMed ID: 4402951
    [No Abstract] [Full Text] [Related]

  • 30. Mouse mixed lymphocyte reactions and cell-mediated lympholysis: genetic control and relevance to antigenic strength.
    Abbasi K, Démant P, Festenstein H, Holmes J, Huber B, Rychiková M.
    Transplant Proc; 1973 Dec; 5(4):1329-37. PubMed ID: 4149544
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Risk of donor lymphocyte infusions following allogeneic bone marrow transplantation.
    van Bekkum DW, Kinwel-Bohré EP.
    Exp Hematol; 1997 Jun; 25(6):478-80. PubMed ID: 9197324
    [Abstract] [Full Text] [Related]

  • 34. Relationship between proliferative and effector phases of the mixed lymphocyte reaction and graft-vs-host reaction.
    Howe M, Berman L, Cohen L.
    J Immunol; 1973 Oct; 111(4):1243-9. PubMed ID: 4147022
    [No Abstract] [Full Text] [Related]

  • 35. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL, Johnson BD, Hanke C, Talib S, Hearst JE.
    J Immunol; 1999 Nov 01; 163(9):5145-56. PubMed ID: 10528221
    [Abstract] [Full Text] [Related]

  • 36. Graft-versus-leukemia effect in allogeneic bone marrow transplantation in mice against several radiation-induced leukemias.
    Aizawa S, Sado T, Kamisaku H, Nemoto K, Yoshida K.
    Bone Marrow Transplant; 1994 Feb 01; 13(2):109-14. PubMed ID: 8205078
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Transient graft-versus-host reaction in the treatment of leukemia in mice.
    Boranić M.
    J Natl Cancer Inst; 1968 Aug 01; 41(2):421-37. PubMed ID: 4876445
    [No Abstract] [Full Text] [Related]

  • 40. Mechanisms in graft-versus-host reactions: an immunogenetic appraisal.
    Uphoff DE.
    Transplant Proc; 1976 Dec 01; 8(4):515-9. PubMed ID: 11581
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.